Bedingungsfaktoren psychopharmakologischer Behandlung bei leichter oder mittelgradiger Intelligenzminderung

BackgroundDuring the past years the provision of mental healthcare for adults with intellectual disabilities (ID) has repeatedly been criticized; however, the number of relevant studies is still relatively few.ObjectiveThe aim of the present study was to identify determinants for utilization of ment...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schützwohl, Matthias (VerfasserIn) , Salize, Hans Joachim (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Deutsch
Veröffentlicht: 2017
In: Der Nervenarzt
Year: 2016, Jahrgang: 88, Heft: 11, Pages: 1273-1280
ISSN:1433-0407
DOI:10.1007/s00115-016-0211-0
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/s00115-016-0211-0
Verlag, Volltext: http://link.springer.com/article/10.1007/s00115-016-0211-0
Volltext
Verfasserangaben:M. Schützwohl, E. Voss, M. Stiawa, H.-J. Salize, B. Puschner, A. Koch
Beschreibung
Zusammenfassung:BackgroundDuring the past years the provision of mental healthcare for adults with intellectual disabilities (ID) has repeatedly been criticized; however, the number of relevant studies is still relatively few.ObjectiveThe aim of the present study was to identify determinants for utilization of mental healthcare services and prescription of psychotropic medication in adults with mild to moderate ID.Material and methodsAnalyses were based on data from 417 adults with mild to moderate ID, which had been collected within the cross-sectional MEMENTA study in three different regions of Germany. Logistic regression analyses were conducted to identify clinical and sociodemographic variables as predictors of utilization of mental healthcare services (n = 282) and psychotropic medication (n = 351).ResultsUtilization of healthcare services and psychotropic medication were both associated with mental disorders and problem behavior. In addition, the likelihood of being treated with psychotropic medication and antipsychotic drugs was higher in adults living in residential homes.ConclusionThe findings indicate a lack of adherence to existing guidelines in the treatment of adults with ID living in residential homes.
Beschreibung:Online publiziert: 16. September 2016
Gesehen am 02.08.2018
Beschreibung:Online Resource
ISSN:1433-0407
DOI:10.1007/s00115-016-0211-0